SANA
Price
$3.19
Change
+$0.27 (+9.25%)
Updated
Jul 3 closing price
Capitalization
719.52M
26 days until earnings call
VERV
Price
$11.28
Change
+$0.07 (+0.62%)
Updated
Jul 3 closing price
Capitalization
1.01B
33 days until earnings call
Interact to see
Advertisement

SANA vs VERV

Header iconSANA vs VERV Comparison
Open Charts SANA vs VERVBanner chart's image
Sana Biotechnology
Price$3.19
Change+$0.27 (+9.25%)
Volume$6.18M
Capitalization719.52M
Verve Therapeutics
Price$11.28
Change+$0.07 (+0.62%)
Volume$1.14M
Capitalization1.01B
SANA vs VERV Comparison Chart in %
Loading...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SANA vs. VERV commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SANA is a Hold and VERV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (SANA: $3.19 vs. VERV: $11.28)
Brand notoriety: SANA and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SANA: 148% vs. VERV: 23%
Market capitalization -- SANA: $719.52M vs. VERV: $1.01B
SANA [@Biotechnology] is valued at $719.52M. VERV’s [@Biotechnology] market capitalization is $1.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SANA’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • SANA’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, both SANA and VERV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SANA’s TA Score shows that 4 TA indicator(s) are bullish while VERV’s TA Score has 7 bullish TA indicator(s).

  • SANA’s TA Score: 4 bullish, 4 bearish.
  • VERV’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, VERV is a better buy in the short-term than SANA.

Price Growth

SANA (@Biotechnology) experienced а +11.15% price change this week, while VERV (@Biotechnology) price change was +0.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

SANA is expected to report earnings on Jul 31, 2025.

VERV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($1.01B) has a higher market cap than SANA($720M). VERV (100.000) and SANA (95.706) have similar YTD gains . SANA (-195.34M) and VERV (-201.62M) have comparable annual earnings (EBITDA) . VERV has more cash in the bank: 497M vs. SANA (105M). VERV has less debt than SANA: VERV (68.6M) vs SANA (91.3M). VERV has higher revenues than SANA: VERV (59.6M) vs SANA (0).
SANAVERVSANA / VERV
Capitalization720M1.01B71%
EBITDA-195.34M-201.62M97%
Gain YTD95.706100.00096%
P/E RatioN/AN/A-
Revenue059.6M-
Total Cash105M497M21%
Total Debt91.3M68.6M133%
TECHNICAL ANALYSIS
Technical Analysis
SANAVERV
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 5 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 9 days ago
86%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HISCX28.170.32
+1.15%
Hartford Small Cap Growth HLS IA
JLCFX73.260.40
+0.55%
JHancock Fundamental Large Cap Core R4
KGDIX32.560.17
+0.52%
DWS Global Small Cap Inst
MXEOX10.550.05
+0.48%
Empower Emerging Markets Equity Inv
MAADX2.470.01
+0.41%
Morgan Stanley Inst Dynamic Value R6

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with VIR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
+9.25%
VIR - SANA
64%
Loosely correlated
-0.37%
CPRX - SANA
43%
Loosely correlated
N/A
AXON - SANA
43%
Loosely correlated
+2.70%
ABSI - SANA
39%
Loosely correlated
+2.97%
GBIO - SANA
39%
Loosely correlated
+1.51%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with ACXP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then ACXP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+0.62%
ACXP - VERV
51%
Loosely correlated
-0.97%
CRSP - VERV
50%
Loosely correlated
+0.97%
BEAM - VERV
49%
Loosely correlated
+0.65%
IVEVF - VERV
46%
Loosely correlated
N/A
PRME - VERV
45%
Loosely correlated
+1.30%
More